Researchers at the University of Cambridge said Wednesday they have developed a way to use biomarkers in a blood test to more accurately diagnose bipolar disorder.
Details of the research were published in the journal JAMA Psychiatry.
Bipolar disorder is often misdiagnosed with major depressive disorder because both have numerous overlapping symptoms but need different pharmacological treatments.
While current blood tests can correctly diagnose up to 30% of bipolar cases, a new test that makes use of biomarkers could allow physicians to differentiate between major depressive disorder and bipolar disorder, the researchers said.
